1,2,4-triazole has been researched along with Colonic Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chtita, S; Ejaz, SA; Iqbal, J; Qais, FA; Riaz, N; Saeed, A; Sarfraz, M; Siddique, F; Tamam, N | 1 |
| Czyżnikowska, Ż; Jawień, P; Strzelecka, M; Świątek, P; Wiatrak, B | 1 |
2 other study(ies) available for 1,2,4-triazole and Colonic Neoplasms
| Article | Year |
|---|---|
Discovery of Phenylcarbamoylazinane-1,2,4-Triazole Amides Derivatives as the Potential Inhibitors of Aldo-Keto Reductases (AKR1B1 & AKRB10): Potential Lead Molecules for Treatment of Colon Cancer.
Topics: Aldo-Keto Reductases; Amides; Colonic Neoplasms; Humans; Molecular Docking Simulation; Triazoles | 2022 |
New Schiff bases derived from dimethylpyridine-1,2,4-triazole hybrid as cytotoxic agents targeting gastrointestinal cancers: Design, synthesis, biological evaluation and molecular docking studies.
Topics: Antineoplastic Agents; Caco-2 Cells; Cell Line, Tumor; Cell Proliferation; Cisplatin; Colonic Neoplasms; Fluorouracil; Humans; Molecular Docking Simulation; Molecular Structure; Schiff Bases; Structure-Activity Relationship | 2023 |